tiprankstipranks
Trending News
More News >

ball - New Portfolio

W K

ball
Individual Investor
Ranked #68,685 out of 825,227 TipRanks' Investors
Success Rate
66%
398 out of 601
profitable transactions
Average Return
42.52%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 10.29%
6-Month Return▲ 63.12%
12-Month Return▲ 64.11%
YTD Return▲ 63.57%
Total Return▲ 99.28%

Best Trade

Opened at
Closed at-
Gain▲ 1758.92%

Bio

Performance

12.88%0-12.88%
▼ 6.38%
▼ 5.57%
▼ 7.95%
Mar 2025
▲ 0.80%
▼ 0.87%
▲ 5.56%
Apr 2025
▲ 11.63%
▲ 6.28%
▲ 12.41%
May 2025
▲ 9.25%
▲ 5.14%
▲ 11.00%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 4.14%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 4.45%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 10.28%
Sep 2025
▲ 7.77%
▲ 1.66%
▲ 8.79%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 6.38%▼ 5.57%▼ 7.95%
▲ 0.80%▼ 0.87%▲ 5.56%
▲ 11.63%▲ 6.28%▲ 12.41%
▲ 9.25%▲ 5.14%▲ 11.00%
▲ 7.60%▲ 2.30%▲ 4.14%
▲ 2.76%▲ 2.05%▲ 4.45%
▲ 12.88%▲ 3.56%▲ 10.28%
▲ 7.77%▲ 1.66%▲ 8.79%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Nektar Therapeutics
0.69%
▲ 5.37%
1
Open
Oct 21, 2025
Nvidia
3.02%
▲ 50.00%
16
Buy
Oct 16, 2025
Mercadolibre
4.57%
▲ 21.41%
9
Buy
Oct 15, 2025
Axon Enterprise
2.28%
▲ 29.90%
7
Buy
Oct 15, 2025
Rocket Lab USA
5.98%
▲ 398.90%
12
Sell
Oct 14, 2025
Amazon
5.46%
▲ 9.53%
22
Buy
Oct 14, 2025
AST SpaceMobile
4.83%
▲ 230.56%
17
Sell
Oct 14, 2025
Navitas Semiconductor
2.5%
▲ 162.93%
5
Sell
Oct 14, 2025
Eos Energy Enterprises
2.76%
▲ 214.85%
4
Sell
Oct 14, 2025
Rubrik, Inc. Class A
1.5%
▲ 9.05%
6
Buy
Oct 07, 2025
Meta Platforms
2.9%
▲ 33.72%
10
Buy
Oct 02, 2025
Mastercard
▲ 26.67%
2
Close
Sep 26, 2025
Stride
0%
▼ 1.35%
8
Sell
Sep 23, 2025
Viking Therapeutics
1.39%
▲ 48.34%
2
Buy
Sep 15, 2025
TransMedics Group
1.1%
▼ 20.86%
24
Open
Sep 10, 2025
Argan
3.34%
▲ 113.64%
11
Buy
Sep 05, 2025
CrowdStrike Holdings
1.9%
▲ 63.71%
5
Buy
Sep 02, 2025
Progressive
0%
▼ 11.30%
6
Sell
Sep 02, 2025
Marvell
▲ 2.76%
2
Close
Sep 02, 2025
Arcutis Biotherapeutics
1.63%
▲ 50.06%
6
Sell
Aug 22, 2025